vs

Side-by-side financial comparison of Dexcom (DXCM) and ADVANCED DRAINAGE SYSTEMS, INC. (WMS). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $693.4M, roughly 1.8× ADVANCED DRAINAGE SYSTEMS, INC.). Dexcom runs the higher net margin — 21.2% vs 13.5%, a 7.7% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 0.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 3.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Advanced Drainage Systems, Inc. (ADS) is an American company that designs, manufactures and markets polypropylene and polyethylene pipes, plastic leach field chambers and systems, septic tanks and accessories, storm retention/detention and septic chambers, polyvinyl chloride drainage structures, fittings, and water filters and water separators. It is the largest maker of high-density polyethylene pipe in the United States. It is headquartered in Hilliard, Ohio. In 2020, 93% of the company's s...

DXCM vs WMS — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.8× larger
DXCM
$1.3B
$693.4M
WMS
Growing faster (revenue YoY)
DXCM
DXCM
+21.2% gap
DXCM
21.6%
0.4%
WMS
Higher net margin
DXCM
DXCM
7.7% more per $
DXCM
21.2%
13.5%
WMS
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
3.0%
WMS

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
DXCM
DXCM
WMS
WMS
Revenue
$1.3B
$693.4M
Net Profit
$267.3M
$93.6M
Gross Margin
62.9%
37.4%
Operating Margin
25.6%
19.7%
Net Margin
21.2%
13.5%
Revenue YoY
21.6%
0.4%
Net Profit YoY
153.6%
15.3%
EPS (diluted)
$0.67
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
WMS
WMS
Q1 26
$1.3B
Q4 25
$1.3B
$693.4M
Q3 25
$1.2B
$850.4M
Q2 25
$1.2B
$829.9M
Q1 25
$1.0B
$615.8M
Q4 24
$1.1B
$690.5M
Q3 24
$994.2M
$782.6M
Q2 24
$1.0B
$815.3M
Net Profit
DXCM
DXCM
WMS
WMS
Q1 26
$267.3M
Q4 25
$267.3M
$93.6M
Q3 25
$283.8M
$156.0M
Q2 25
$179.8M
$143.9M
Q1 25
$105.4M
$77.2M
Q4 24
$151.7M
$81.2M
Q3 24
$134.6M
$130.4M
Q2 24
$143.5M
$161.4M
Gross Margin
DXCM
DXCM
WMS
WMS
Q1 26
62.9%
Q4 25
62.9%
37.4%
Q3 25
60.5%
40.0%
Q2 25
59.5%
39.8%
Q1 25
56.9%
36.7%
Q4 24
58.9%
35.0%
Q3 24
59.7%
37.6%
Q2 24
62.4%
40.8%
Operating Margin
DXCM
DXCM
WMS
WMS
Q1 26
25.6%
Q4 25
25.6%
19.7%
Q3 25
20.1%
26.3%
Q2 25
18.4%
24.8%
Q1 25
12.9%
19.0%
Q4 24
17.0%
18.4%
Q3 24
15.3%
23.9%
Q2 24
15.7%
27.7%
Net Margin
DXCM
DXCM
WMS
WMS
Q1 26
21.2%
Q4 25
21.2%
13.5%
Q3 25
23.5%
18.3%
Q2 25
15.5%
17.3%
Q1 25
10.2%
12.5%
Q4 24
13.6%
11.8%
Q3 24
13.5%
16.7%
Q2 24
14.3%
19.8%
EPS (diluted)
DXCM
DXCM
WMS
WMS
Q1 26
$0.67
Q4 25
$0.67
$1.19
Q3 25
$0.70
$1.99
Q2 25
$0.45
$1.84
Q1 25
$0.27
$0.99
Q4 24
$0.37
$1.04
Q3 24
$0.34
$1.67
Q2 24
$0.35
$2.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
WMS
WMS
Cash + ST InvestmentsLiquidity on hand
$917.7M
$1.0B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$1.9B
Total Assets
$6.3B
$4.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
WMS
WMS
Q1 26
$917.7M
Q4 25
$917.7M
$1.0B
Q3 25
$1.8B
$812.9M
Q2 25
$1.2B
$638.3M
Q1 25
$904.9M
$463.3M
Q4 24
$606.1M
$488.9M
Q3 24
$621.2M
$613.0M
Q2 24
$939.2M
$541.6M
Total Debt
DXCM
DXCM
WMS
WMS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
$1.3B
Q4 24
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
WMS
WMS
Q1 26
$2.7B
Q4 25
$2.7B
$1.9B
Q3 25
$2.7B
$1.8B
Q2 25
$2.6B
$1.7B
Q1 25
$2.3B
$1.5B
Q4 24
$2.1B
$1.5B
Q3 24
$2.0B
$1.4B
Q2 24
$2.4B
$1.3B
Total Assets
DXCM
DXCM
WMS
WMS
Q1 26
$6.3B
Q4 25
$6.3B
$4.1B
Q3 25
$7.5B
$4.1B
Q2 25
$7.3B
$3.9B
Q1 25
$6.8B
$3.7B
Q4 24
$6.5B
$3.6B
Q3 24
$6.4B
$3.5B
Q2 24
$6.8B
$3.4B
Debt / Equity
DXCM
DXCM
WMS
WMS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
0.83×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
WMS
WMS
Operating Cash FlowLast quarter
$269.3M
Free Cash FlowOCF − Capex
$183.6M
FCF MarginFCF / Revenue
26.5%
Capex IntensityCapex / Revenue
12.4%
Cash ConversionOCF / Net Profit
2.88×
TTM Free Cash FlowTrailing 4 quarters
$577.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
WMS
WMS
Q1 26
Q4 25
$294.0M
$269.3M
Q3 25
$659.9M
$234.9M
Q2 25
$303.0M
$275.0M
Q1 25
$183.8M
$41.2M
Q4 24
$301.4M
$189.9M
Q3 24
$199.5M
$166.9M
Q2 24
$279.4M
$183.4M
Free Cash Flow
DXCM
DXCM
WMS
WMS
Q1 26
Q4 25
$192.1M
$183.6M
Q3 25
$579.4M
$176.4M
Q2 25
$208.9M
$222.4M
Q1 25
$96.8M
$-5.3M
Q4 24
$176.8M
$135.7M
Q3 24
$88.3M
$112.4M
Q2 24
$213.3M
$125.7M
FCF Margin
DXCM
DXCM
WMS
WMS
Q1 26
Q4 25
15.3%
26.5%
Q3 25
47.9%
20.7%
Q2 25
18.1%
26.8%
Q1 25
9.3%
-0.9%
Q4 24
15.9%
19.7%
Q3 24
8.9%
14.4%
Q2 24
21.2%
15.4%
Capex Intensity
DXCM
DXCM
WMS
WMS
Q1 26
Q4 25
8.1%
12.4%
Q3 25
6.7%
6.9%
Q2 25
8.1%
6.3%
Q1 25
8.4%
7.6%
Q4 24
11.2%
7.9%
Q3 24
11.2%
7.0%
Q2 24
6.6%
7.1%
Cash Conversion
DXCM
DXCM
WMS
WMS
Q1 26
Q4 25
1.10×
2.88×
Q3 25
2.33×
1.51×
Q2 25
1.69×
1.91×
Q1 25
1.74×
0.53×
Q4 24
1.99×
2.34×
Q3 24
1.48×
1.28×
Q2 24
1.95×
1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

WMS
WMS

Reportable Segment Aggregation Before Other Operating Segment$557.3M80%
Other$85.5M12%
Pipe$35.5M5%
Allied Products And Other$15.0M2%

Related Comparisons